Risk Assessment and Monitoring of Chronic Pulmonary Hypertension in Premature Infants

The original description of bronchopulmonary dysplasia (BPD) included the finding that pulmonary vascular disease and right ventricular hypertrophy are associated with the high mortality of the disease.1 Today, chronic pulmonary hypertension persists as a major cause of morbidity and mortality of extremely premature infants.2,3 Although pulmonary hypertension can present in premature infants at different stages with varying hemodynamic signatures during the neonatal course, chronic pulmonary hypertension is characterized by late, sustained, and often progressive elevation of pulmonary artery pressure (PAP) that is diagnosed beyond the first few weeks of age.

Source: The Journal of Pediatrics - November 13, 2019 Category: Pediatrics Authors: Philip T. Levy, Amish Jain, Hythem Nawaytou, David Teitel, Roberta Keller, Jeffery Fineman, Robin Steinhorn, Steven H. Abman, Patrick J. McNamara, Pediatric Pulmonary Hypertension Network (PPHNet) Tags: Workshop/Symposium Summary Source Type: research